Literature DB >> 25581144

The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.

Andrew Kolodny1, David T Courtwright, Catherine S Hwang, Peter Kreiner, John L Eadie, Thomas W Clark, G Caleb Alexander.   

Abstract

Public health authorities have described, with growing alarm, an unprecedented increase in morbidity and mortality associated with use of opioid pain relievers (OPRs). Efforts to address the opioid crisis have focused mainly on reducing nonmedical OPR use. Too often overlooked, however, is the need for preventing and treating opioid addiction, which occurs in both medical and nonmedical OPR users. Overprescribing of OPRs has led to a sharp increase in the prevalence of opioid addiction, which in turn has been associated with a rise in overdose deaths and heroin use. A multifaceted public health approach that utilizes primary, secondary, and tertiary opioid addiction prevention strategies is required to effectively reduce opioid-related morbidity and mortality. We describe the scope of this public health crisis, its historical context, contributing factors, and lines of evidence indicating the role of addiction in exacerbating morbidity and mortality, and we provide a framework for interventions to address the epidemic of opioid addiction.

Entities:  

Keywords:  addiction; chronic pain; heroin; opioid; overdose deaths; prescription drug abuse

Mesh:

Year:  2015        PMID: 25581144     DOI: 10.1146/annurev-publhealth-031914-122957

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  395 in total

1.  Heroin use onset among nonmedical prescription opioid users in the club scene.

Authors:  Hilary L Surratt; Steven P Kurtz; Mance Buttram; Maria A Levi-Minzi; Maria E Pagano; Theodore J Cicero
Journal:  Drug Alcohol Depend       Date:  2017-07-26       Impact factor: 4.492

2.  Emergency department visits by pediatric patients for poisoning by prescription opioids.

Authors:  Allison Tadros; Shelley M Layman; Stephen M Davis; Rachel Bozeman; Danielle M Davidov
Journal:  Am J Drug Alcohol Abuse       Date:  2016-07-11       Impact factor: 3.829

3.  Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Michael I Fingerhood; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2017-07-11       Impact factor: 4.492

4.  Large-scale Analysis of Opioid Poisoning Related Hospital Visits in New York State.

Authors:  Xin Chen; Yu Wang; Xiaxia Yu; Elinor Schoenfeld; Mary Saltz; Joel Saltz; Fusheng Wang
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

5.  Randomized program evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM): A research and clinical operations partnership to examine effectiveness.

Authors:  Taeko Minegishi; Austin B Frakt; Melissa M Garrido; Walid F Gellad; Leslie R M Hausmann; Eleanor T Lewis; Steven D Pizer; Jodie A Trafton; Elizabeth M Oliva
Journal:  Subst Abus       Date:  2019-01-08       Impact factor: 3.716

Review 6.  Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.

Authors:  Brandon D L Marshall; Traci C Green; Jesse L Yedinak; Scott E Hadland
Journal:  Int J Drug Policy       Date:  2016-02-04

7.  Health Care Utilization of Opioid Overdose Decedents with No Opioid Analgesic Prescription History.

Authors:  Ali B Abbasi; Elizabeth Salisbury-Afshar; Dejan Jovanov; Craig Berberet; Ponni Arunkumar; Steven E Aks; Jennifer E Layden; Mai T Pho
Journal:  J Urban Health       Date:  2019-02       Impact factor: 3.671

8.  Resistance exercise decreases heroin self-administration and alters gene expression in the nucleus accumbens of heroin-exposed rats.

Authors:  Mark A Smith; Gaylen E Fronk; Jean M Abel; Ryan T Lacy; Sarah E Bills; Wendy J Lynch
Journal:  Psychopharmacology (Berl)       Date:  2018-02-02       Impact factor: 4.530

9.  Trends in Abstinence and Retention Associated with a Medication-Assisted Treatment Program for People with Opioid Use Disorders.

Authors:  Kimberly D Brunisholz; Andrew J Knighton; Amulya Sharma; Lisa Nichols; Kristen Reisig; Jed Burton; Debbie Scovill; Carolyn Tometich; Mark Foote; Shelly Read; Scott Whittle
Journal:  Prog Community Health Partnersh       Date:  2020

10.  A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations.

Authors:  Daniel M Hartung; Lindsey Alley; Gillian Leichtling; P Todd Korthuis; Christi Hildebran
Journal:  Addict Behav       Date:  2018-05-01       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.